Pancreatic cancer: Dr. Pudlarz praises 'new generation targeted therapy' that inhibits gene mutation
Oliver Farry is pleased to welcome Dr. Thomas Pudlarz, Medical Oncologist and Head of the pancreatic care pathway within the 'Interception' program at the Gustave-Roussy Institute. For decades, pancreatic cancer has remained one of oncology's most...